For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Once enabled, click here to view the site.

singup link button why should I sign up?
Login as Volunteer Login as Study team member
OR

Studies you may be eligible for. 3

Based on the information you provided, we found the following studies.

  • A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients with Advanced Sarcomas The study goal is to learn if treatment with pembrolizumab is useful in patients with advanced soft tissue and bone sarcomas.Pembrolizumab might or might not slow down the growth of your tumor, or shrink your tumor. Pembrolizumab is FDA approved to treat another type of cancer ¿ melanoma. This study is researching all of the following topics: Cancerous bone tumor, Osteosarcoma Sarcoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Survey of Cancer Survivors Treatment Preferences for Cancer-Related Fatigue The purpose of our study is to see how cancer patients and survivors would like to learn about acupressure or diet as a treatment for their cancer symptoms like fatigue as well as general information about technology used and their environment. This study is researching all of the following topics: Adrenal cancer BCC, Basal cell skin cancer Bile duct cancer Bladder cancer Bone cancer Brain cancer Breast cancer Cancerous bone tumor, Osteosarcoma Cervical cancer Colon Cancer ( Malignant tumor of colon ) Colorectal / Colon / Rectal cancer Esophagus cancer Fallopian tube cancer HCC, Liver cancer HNPCC, Lynch Syndrome ( Hereditary NonPolyposis Colorectal Cancer ) Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer NPC, Nasal cancer Oral / Mouth cancer Ovarian cancer Pancreatic cancer PPC, Primary peritoneal cancer Prostate cancer Salivary Gland Cancer Skin Cancer ( Malignant neoplasm of skin ) Squamous cell skin cancer Thyroid cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions and Healthy volunteers
    • More than 18 years old
  • Phase I/II Trial of experimental drug ganetespib in combination with the mTOR inhibitor sirolimus for patients with unresectable or metastatic malignant peripheral nerve sheath tumors (MPNST) Study purpose:find highest safe dose, side effects and any benefits of ganetespib when given with sirolimus; test whether 3D-MRI is better at seeing MPNST than traditional scans This study is researching all of the following topics: Cancerous bone tumor, Osteosarcoma Sarcoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old